Telratolimod

CAS No. 1359993-59-1

Telratolimod( MEDI9197 | 3M-052 )

Catalog No. M26840 CAS No. 1359993-59-1

Telratolimod is a toll-like receptors 7/8 agonist. It has an antitumor activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 236 In Stock
5MG 353 In Stock
10MG 528 In Stock
25MG 851 In Stock
50MG 1135 In Stock
100MG 1535 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Telratolimod
  • Note
    Research use only, not for human use.
  • Brief Description
    Telratolimod is a toll-like receptors 7/8 agonist. It has an antitumor activity.
  • Description
    Telratolimod is a toll-like receptors 7/8 agonist. It has an antitumor activity.(In Vivo):Telratolimod (50 μg) suppresses the tumor volume and more effectively blocks tumor growth in combination with CpG ODN in BALB/c mice bearing CT26 colon carcinoma cells. Telratolimod (100 μg) plus 200 μg of CpG ODN slows tumor growth and prolongs the survival of mice bearing large tumors .
  • In Vitro
    Telratolimod (3M-052) is a toll like receptors 7/8 (TLR7/8) agonist, with antitumor activity.
  • In Vivo
    Telratolimod (50 μg) inhibits the tumor volume, and more potently blocks tumor gowth in combination with CpG ODN in BALB/c mice bearing CT26 colon carcinoma cells. Telratolimod (100 μg) plus 200 μg of CpG ODN slows tumor growth and prolongs survival of mice bearing large tumors.
  • Synonyms
    MEDI9197 | 3M-052
  • Pathway
    Immunology/Inflammation
  • Target
    TLR
  • Recptor
    LpxC
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1359993-59-1
  • Formula Weight
    593.901
  • Molecular Formula
    C36H59N5O2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 62.5 mg/mL (105.24 mM)
  • SMILES
    CCCCCCCCCCCCCCCCCC(=O)NCCCCOn1c(CCCC)nc2c(N)nc3ccccc3c12
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Ushiyama F, et al. Lead optimization of 2-hydroxymethyl imidazoles as non-hydroxamate LpxC inhibitors: Discovery of TP0586532. Bioorg Med Chem. 2021;30:115964.
molnova catalog
related products
  • CU-115

    CU-115 is a selective antagonist of TLR8 with IC50s of 1.04 μM and >50 μM for TLR8 and TLR7, respectively.

  • Pam3CSK4

    Pam3CSK4 is a synthetic triacylated lipopeptide (LP) that mimics the acylated amino terminus of bacterial LPs.

  • Isatoribine

    Isatoribine (ANA245;7-Thia-8-oxoguanosine;Immunosine) is a nucleoside analogue, selective agonist of TLR7 with significant antiviral effect and mmunoenhancing activity.